Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Israel Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20092
20101
20112
20124
20132
20141
20171
20183
20193
20211
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated10
Active, not recruiting3
Recruiting2
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GlaxoSmithKline3
Eli Lilly and Company2
Pfizer2
United Therapeutics2
Amgen1
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases28
Myocardial Infarction9
Stroke8
Diabetes Mellitus, Type 25
Hypertension5
Heart Diseases4
Heart Failure4
Hyperlipidemias4
Vascular Diseases4
Acute Coronary Syndrome3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.